Intraday News Mover:: Teva Pharmaceutical Industries Limited, (NYSE: TEVA)


On Monday, November 16, 2020, the Company, Teva Pharmaceutical Industries Limited, TEVA stock construct a change of 1.48 percent (Gain) in a total of its share price and having its trading value $9.63, which belongs to Healthcare sector and Drug Manufacturers – Specialty & Generic industry. The company?s Market capitalization was $10.69B with the total Outstanding Shares of 1.10B.


P/S, P/E, P/B & P/C values of (NYSE: TEVA):


Teva Pharmaceutical Industries Limited institutional ownership is standing at 52.8 percent, while insider ownership is 1.02 percent. As of now, TEVA has a P/S, P/E and, P/B values of 0.66, 0, and 1.1 respectively. Its P/Cash is valued at 5.85.


The stock SMA50 is now at 5.35 percent. In looking, the SMA 200 we see that the stock has seen a -8.89 percent. The Company?s net profit margin for the 12 months at -24.9 percent. Comparatively, the gazes have a Gross margin of 47.3 percent.

Profitability ratios:


Looking into the profitability ratios of TEVA stock, an investor will find its ROE, ROA, ROI standing at -31.6 percent, -7.4 percent and, -0.4 percent, respectively.

Beta Factor:


A beta factor is used to measure the volatility of the stock. The stock remaining at 3.66 percent volatile for the week and 3.84 percent for the month.

Gross / Operating Margins of TEVA:


It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 47.3 percent & Operating Margin seen at -23.6 percent.

Target Price:


Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Teva Pharmaceutical Industries Limited recorded it at $11.87.

Historical Performance In The News:


Taking a look at the performance of Teva Pharmaceutical Industries Limited stock, an investor will come to know that the weekly performance for this stock is valuing at -0.41 percent, resulting in a performance for the month at 2.34 percent.

Therefore, the stated figure displays a quarterly performance of -8.11 percent, bringing six-month performance to -19.82 percent and year to date performance of -1.73 percent. As of now, Teva Pharmaceutical Industries Limited has a P/S, P/E and, P/B values of 0.66, 0, and 1.1 respectively. Its P/Cash is valued at 5.85.

Earnings per Share Details of Teva Pharmaceutical Industries Limited:


The EPS of TEVA is strolling at -3.68, measuring its EPS growth this year at 59.4 percent. As a result, the company has an EPS growth of 5.37 percent for the approaching year.